Stay updated on APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:16:25.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to the safety and efficacy of APX005M with Gemcitabine and Nab-Paclitaxel with or without Nivolumab in patients with previously untreated metastatic pancreatic adenocarcinoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:22:31.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    45%
    Check dated 2024-05-22T20:53:54.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:29:49.000Z thumbnail image

Stay in the know with updates to APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.